Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms
Ken-Hong Lim,
Ken-Hong Lim,
Shinobu Matsuura,
Bing Xu,
Bing Xu
Affiliations
Ken-Hong Lim
Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei City, Taiwan
Ken-Hong Lim
Department of Medicine, MacKay Medical College, New Taipei City, Taiwan
Shinobu Matsuura
Department of Medicine–Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA, United States
Bing Xu
Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China
Bing Xu
Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, China